171 related articles for article (PubMed ID: 31338907)
1. Antitumour effects of metformin and curcumin in human papillomavirus positive and negative head and neck cancer cells.
Lindsay C; Kostiuk M; Conrad D; O'Connell DA; Harris J; Seikaly H; Biron VL
Mol Carcinog; 2019 Nov; 58(11):1946-1959. PubMed ID: 31338907
[TBL] [Abstract][Full Text] [Related]
2. Association of lnc-IL17RA-11 with increased radiation sensitivity and improved prognosis of HPV-positive HNSCC.
Song L; Xie H; Tong F; Yan B; Zhang S; Fu E; Jing Q; Wei L
J Cell Biochem; 2019 Oct; 120(10):17438-17448. PubMed ID: 31119798
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal Cancer Cell Lines Regardless of HPV Status.
Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation.
Liu C; Sadat SH; Ebisumoto K; Sakai A; Panuganti BA; Ren S; Goto Y; Haft S; Fukusumi T; Ando M; Saito Y; Guo T; Tamayo P; Yeerna H; Kim W; Hubbard J; Sharabi AB; Gutkind JS; Califano JA
Clin Cancer Res; 2020 Jun; 26(11):2693-2703. PubMed ID: 31932491
[TBL] [Abstract][Full Text] [Related]
5. Oropharyngeal HPV Detection Techniques in HPV-associated Head and Neck Cancer Patients.
Eggersmann TK; Baumeister P; Kumbrink J; Mayr D; Schmoeckel E; Thaler CJ; Dannecker C; Jeschke U; Nagler T; Mahner S; Sharaf K; Gallwas JKS
Anticancer Res; 2020 Apr; 40(4):2117-2123. PubMed ID: 32234904
[TBL] [Abstract][Full Text] [Related]
6. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
Du S; Liu K; Gao P; Li Z; Zheng J
Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
[TBL] [Abstract][Full Text] [Related]
7. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
[TBL] [Abstract][Full Text] [Related]
8. Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas.
An Y; Jeon J; Sun L; Derakhshan A; Chen J; Carlson S; Cheng H; Silvin C; Yang X; Van Waes C; Chen Z
Sci Rep; 2021 Mar; 11(1):6392. PubMed ID: 33737574
[TBL] [Abstract][Full Text] [Related]
9. HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma.
Fleming JC; Woo J; Moutasim K; Mellone M; Frampton SJ; Mead A; Ahmed W; Wood O; Robinson H; Ward M; Woelk CH; Ottensmeier CH; King E; Kim D; Blaydes JP; Thomas GJ
Br J Cancer; 2019 Feb; 120(3):356-367. PubMed ID: 30655616
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.
Lindsay CD; Kostiuk MA; Harris J; O'Connell DA; Seikaly H; Biron VL
Clin Epigenetics; 2017; 9():95. PubMed ID: 28878842
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinoma.
Broutian TR; Jiang B; Li J; Akagi K; Gui S; Zhou Z; Xiao W; Symer DE; Gillison ML
Cancer Lett; 2020 Apr; 476():23-33. PubMed ID: 31958486
[TBL] [Abstract][Full Text] [Related]
12. Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV
Xiao R; An Y; Ye W; Derakhshan A; Cheng H; Yang X; Allen C; Chen Z; Schmitt NC; Van Waes C
Clin Cancer Res; 2019 Nov; 25(21):6463-6474. PubMed ID: 31266830
[TBL] [Abstract][Full Text] [Related]
13. Demethylation Therapy as a Targeted Treatment for Human Papillomavirus-Associated Head and Neck Cancer.
Biktasova A; Hajek M; Sewell A; Gary C; Bellinger G; Deshpande HA; Bhatia A; Burtness B; Judson B; Mehra S; Yarbrough WG; Issaeva N
Clin Cancer Res; 2017 Dec; 23(23):7276-7287. PubMed ID: 28916527
[No Abstract] [Full Text] [Related]
14. Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma.
Robinson AM; Rathore R; Redlich NJ; Adkins DR; VanArsdale T; Van Tine BA; Michel LS
Cell Death Dis; 2019 Nov; 10(11):867. PubMed ID: 31727874
[TBL] [Abstract][Full Text] [Related]
15. ATR inhibition sensitizes HPV
Leonard BC; Lee ED; Bhola NE; Li H; Sogaard KK; Bakkenist CJ; Grandis JR; Johnson DE
Oral Oncol; 2019 Aug; 95():35-42. PubMed ID: 31345392
[TBL] [Abstract][Full Text] [Related]
16. The role of Glial cell derived neurotrophic factor in head and neck cancer.
Cao H; He Q; Eyben RV; Bloomstein J; Nambiar DK; Viswanathan V; Aggarwal S; Kwok S; Liang R; Koong AJ; Lewis JS; Kong C; Xiao N; Le QT
PLoS One; 2020; 15(2):e0229311. PubMed ID: 32084217
[TBL] [Abstract][Full Text] [Related]
17. Prevention of tumor growth driven by PIK3CA and HPV oncogenes by targeting mTOR signaling with metformin in oral squamous carcinomas expressing OCT3.
Madera D; Vitale-Cross L; Martin D; Schneider A; Molinolo AA; Gangane N; Carey TE; McHugh JB; Komarck CM; Walline HM; William WN; Seethala RR; Ferris RL; Gutkind JS
Cancer Prev Res (Phila); 2015 Mar; 8(3):197-207. PubMed ID: 25681087
[TBL] [Abstract][Full Text] [Related]
18. HPV mRNA expression profiling in head and neck squamous cell carcinomas.
Ragos V; Mastronikolis NS; Tsiambas E; Fotiades PP
J BUON; 2018; 23(2):535-536. PubMed ID: 29745107
[No Abstract] [Full Text] [Related]
19. Comparative Gene Expression Profiling of Tobacco-Associated HPV-Positive versus Negative Oral Squamous Carcinoma Cell Lines.
Lepore S; Lettini G; Condelli V; Sisinni L; Piscazzi A; Simeon V; Zoppoli P; Pedicillo MC; Natalicchio MI; Pietrafesa M; Landriscina M
Int J Med Sci; 2020; 17(1):112-124. PubMed ID: 31929745
[No Abstract] [Full Text] [Related]
20. FGF Expression in HPV16-positive and -negative SCC After Treatment With Small-molecule Tyrosine Kinase Inhibitors and Everolimus.
Huber L; Birk R; Knuettel M; Rotter N; Aderhold C; Scherl C; Lammert A; Jungbauer F; Kramer B
Anticancer Res; 2020 Oct; 40(10):5621-5630. PubMed ID: 32988886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
